News
188 posts · page 4 of 19
Neurological Diagnostic Devices Market Set for Decade of Growth Through 2035
Driven by an aging global population and the integration of artificial intelligence, the neurological diagnostics sector is poised for significant expansion over the next 10 years.
Innovative Diagnostic Tools Emerge to Address the Challenges of Long Covid Detection
Medical researchers are developing new testing frameworks to identify the biological markers of Long Covid, aiming to provide clarity for millions of undiagnosed patients.
India Establishes Specialized Medical Device Parks in Tamil Nadu, UP, and Madhya Pradesh
The Union Government is launching dedicated manufacturing hubs to reduce import reliance and strengthen India's domestic medical technology infrastructure.
The Shift Toward Software-Defined Medical Devices: Transforming Healthcare Infrastructure
Medical technology is undergoing a fundamental shift as software-driven architectures replace traditional, hardware-centric designs to improve patient outcomes.
AMTZ Designated as Official Awarding Body for Medical Device Sector Skill Development
The Andhra Pradesh MedTech Zone (AMTZ) has achieved a major milestone by becoming a recognized awarding body for specialized training and certification in medical technology.
Siegfried Strengthens European Footprint with New API Plant Launch in Germany
Swiss CDMO Siegfried has inaugurated a large-scale Active Pharmaceutical Ingredient production site in Germany, enhancing its global manufacturing capacity.
Siegfried Strengthens European Manufacturing with New Large-Scale API Plant in Germany
Swiss CDMO Siegfried Group has inaugurated a major active pharmaceutical ingredient facility in Minden, boosting global drug supply chains and European industrial capacity.
Immix Biopharma Price Target Surges to $19.79 as Analysts Forecast 117% Growth
Wall Street analysts have significantly increased their valuation for Immix Biopharma, signaling strong confidence in the company's clinical pipeline and market potential.
RedHill Biopharma Secures $19.4 Million Through Strategic Private Placement
Specialty biopharmaceutical firm RedHill Biopharma has announced a private placement deal to bolster its capital reserves for ongoing clinical and commercial operations.
Accelerating Commercial Readiness: Navigating Rapid FDA Approval Timelines
Emerging biopharma firms face immense pressure to align commercial strategies with the FDA's increasingly fast-tracked regulatory pathways.